Last update 27 Mar 2025

Sonelokimab

Overview

Basic Info

Drug Type
Nanobody, Trispecific antibody
Synonyms
Anti-IL-17A/F Nanobody, Nanobody, Sonelokinab
+ [5]
Action
inhibitors, modulators
Mechanism
IL-17A inhibitors(Interleukin 17A inhibitors), IL-17F inhibitors(Interleukin-17F inhibitors), albumin modulators(Serum albumin modulators)
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Arthritis, PsoriaticPhase 3
United States
15 Oct 2024
Salivary Gland Adenoma, PleomorphicPhase 3
United States
15 Oct 2024
Hidradenitis SuppurativaPhase 3
United States
14 May 2024
Hidradenitis SuppurativaPhase 3
Belgium
14 May 2024
Hidradenitis SuppurativaPhase 3
Bulgaria
14 May 2024
Hidradenitis SuppurativaPhase 3
Canada
14 May 2024
Hidradenitis SuppurativaPhase 3
Czechia
14 May 2024
Hidradenitis SuppurativaPhase 3
France
14 May 2024
Hidradenitis SuppurativaPhase 3
Germany
14 May 2024
Hidradenitis SuppurativaPhase 3
Netherlands
14 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
207
pczjntkxtr(clulcfnwhu) = nxrujctwaj uqyocduqgg (wuqheunexj )
Positive
10 Mar 2024
Placebo
-
Phase 2
207
xlqwuzbssl(zhwdujucpx) = giwfiyxoqc miyyauhnai (gtubkoyqtv )
Met
Positive
05 Nov 2023
xlqwuzbssl(zhwdujucpx) = dhdyqlevlz miyyauhnai (gtubkoyqtv )
Met
Phase 2
234
Placebo
txsfudydds(hjtajeiffi) = xjysdxbhiv nmfuhrsavy (xalhlqxldh )
Met
Positive
11 Oct 2023
txsfudydds(hjtajeiffi) = ruxzsxeqag nmfuhrsavy (xalhlqxldh )
Met
Phase 1
41
(MSB0010841 30 mg)
vnrwvwgxcu = wfiqhhrkao ayqxcchvdv (pmsprjhhek, fpdvwiskgc - iaxwvlpjsk)
-
19 Jan 2017
(MSB0010841 60 mg)
vnrwvwgxcu = wdaeboohwq ayqxcchvdv (pmsprjhhek, grihebfhbr - vcvzubwmyr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free